Covance (Fortrea)

Covance was a contract research organization (CRO) acquired by Labcorp in 2015 and rebranded as Labcorp Drug Development in 2021. In 2023, the clinical development business was spun off as Fortrea, an independent CRO headquartered in Durham, North Carolina, operating in 90+ countries and serving the pharmaceutical, biotechnology, and medical device industries with clinical trial management, central laboratory, and bioanalytical services. No public API or developer portal is currently published; integrations are arranged through sponsor and partner agreements.

Covance (Fortrea) is profiled on the APIs.io network. Tagged areas include Bioanalytical, Biotechnology, Central Laboratory, Clinical Development, and Clinical Trials.

Covance (Fortrea)’s developer surface includes engineering blog and 11 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

BioanalyticalBiotechnologyCentral LaboratoryClinical DevelopmentClinical TrialsContract Research OrganizationCRODrug DevelopmentPharmaceutical

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.4/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.4 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/covance: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Covance Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Press 5

Recent news and press coverage referencing this provider.

Build 1

SDKs, sample code, and the tooling you integrate with

ClinicalDevelopment

ClinicalDevelopment

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

ContactSales

ContactSales

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 6

The organization behind the API

Website

LegacyWebsite

About

LinkedInFortrea

LinkedInCovance

Blog

Other 1

Properties that don't map to a standard resource type

LabcorpDrugDevelopment

LabcorpDrugDevelopment

Source (apis.yml)

aid: covance
name: Covance (Fortrea)
kind: company
description: Covance was a contract research organization (CRO) acquired by Labcorp in 2015 and rebranded as Labcorp Drug
  Development in 2021. In 2023, the clinical development business was spun off as Fortrea, an independent CRO headquartered
  in Durham, North Carolina, operating in 90+ countries and serving the pharmaceutical, biotechnology, and medical device
  industries with clinical trial management, central laboratory, and bioanalytical services. No public API or developer portal
  is currently published; integrations are arranged through sponsor and partner agreements.
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/covance.png
url: https://raw.githubusercontent.com/api-evangelist/covance/refs/heads/main/apis.yml
type: Index
access: 3rd-Party
position: Consuming
created: '2024-01-01'
modified: '2026-04-28'
tags:
- Bioanalytical
- Biotechnology
- Central Laboratory
- Clinical Development
- Clinical Trials
- Contract Research Organization
- CRO
- Drug Development
- Pharmaceutical
apis: []
common:
- type: DomainSecurity
  url: security/covance-domain-security.yml
- type: Website
  url: https://www.fortrea.com
- type: LegacyWebsite
  url: https://www.covance.com
- type: LabcorpDrugDevelopment
  url: https://drugdevelopment.labcorp.com/
- type: About
  url: https://www.fortrea.com/about-us
- type: ClinicalDevelopment
  url: https://www.fortrea.com/services
- type: ContactSales
  url: https://www.fortrea.com/contact-us
- type: LinkedInFortrea
  url: https://www.linkedin.com/company/fortrea/
- type: LinkedInCovance
  url: https://www.linkedin.com/company/covancedrugdevelopment
- type: PrivacyPolicy
  url: https://www.fortrea.com/privacy-policy
- type: TermsOfService
  url: https://www.fortrea.com/terms-of-use
- url: https://www.fortrea.com/insights
  type: Blog
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com

Covance (Fortrea)

Kin Score

Security Posture 1

Covance Domain Security

Press 5

Covance Inc. Board Authorizes $250 Million Stock Buyback

Covance and Lilly Reach Strategic Agreement

Covance – Specialized IT Services Provider

Covance Announces Plans to Build New Drug Development ...

Covance and Definiens Collaborate to Integrate Digital ...

Resources